U.S. Market

Dr. Reddy’s Laboratories announces the launch of Pregabalin Capsules in the U.S. Market

Hyderabad, July 30, 2019:, Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred…

5 years ago

Dr. Reddy’s announces the launch of the over-the-counter store brand equivalent of Mucinex® D Extended Release Tablets in two strengths in the U.S. Market

Hyderabad, July 09, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to…

5 years ago

Dr. Reddy’s Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL)Single-dose Vial in the U.S. Market

Hyderabad, July 04, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred…

5 years ago

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

New Delhi, February 05, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420